Skip to main content
Canna~Fangled Abstracts

Putative Activation of the CB1 Cannabinoid Receptors Prevents Anxiety-Like Behavior, Oxidative Stress, and GABA Decrease in the Brain of Zebrafish Submitted to Acute Restraint Stress

By January 18, 2021February 5th, 2021No Comments

Abstract

Anxiety disorder is a well-recognized condition observed in subjects submitted to acute stress. Although the brain mechanisms underlying this disorder remain unclear, the available evidence indicates that oxidative stress and GABAergic dysfunction mediate the generation of stress-induced anxiety. Cannabinoids are known to be efficient modulators of behavior, given that the activation of the cannabinoid receptors type-1 (CB1 receptors) induces anxiolytic-like effects in animal models. In the present study, we aimed to describe the effects of the stimulation of the CB1 receptors on anxiety-like behavior, oxidative stress, and the GABA content of the brains of zebrafish submitted to acute restraint stress (ARS). The animals submitted to the ARS protocol presented evident anxiety-like behavior with increased lipid peroxidation in the brain tissue. The evaluation of the levels of GABA in the zebrafish telencephalon presented decreased levels of GABA in the ARS group in comparison with the control. Treatment with ACEA, a specific CB1 receptor agonist, prevented ARS-induced anxiety-like behavior and oxidative stress in the zebrafish brain. ACEA treatment also prevented a decrease in GABA in the telencephalon of the animals submitted to the ARS protocol. Overall, these preclinical data strongly suggest that the CB1 receptors represent a potential target for the development of the treatment of anxiety disorders elicited by acute stress.

 

Keywords: CB1 receptors, GABA, acute stress, anxiety, oxidative stress, zebrafish

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1

Figure 2

Figure 3

References

    1. Alonso J., Liu Z., Evans-Lacko S., Sadikova E., Sampson N., Chatterji S., et al. . (2018). Treatment gap for anxiety disorders is global: results of the world mental health surveys in 21 countries. Depress. Anxiety 35, 195–208. 10.1002/da.22711 – DOI – PMC – PubMed
    1. Assad N., Luz W. L., Santos-Silva M., Carvalho T., Moraes S., Picanço-Diniz D., et al. . (2020). Acute restraint stress evokes anxiety-like behavior mediated by telencephalic inactivation and gabaergic dysfunction in zebrafish brains. Sci. Rep. 10:5551. 10.1038/s41598-020-62077-w – DOI – PMC – PubMed
    1. Bandelow B., Michaelis S. (2015). Epidemiology of anxiety disorders in the 21st century. Dialogues Clin. Neurosci. 17, 327–335. 10.31887/DCNS.2015.17.3/bbandelow – DOI – PMC – PubMed
    1. Cachat J., Canavello P., Elegante M., Bartels B., Hart P., Bergner C., et al. . (2010). Modeling withdrawal syndrome in zebrafish. Behav. Brain Res. 208, 371–376. 10.1016/j.bbr.2009.12.004 – DOI – PubMed
    1. Caramillo E. M., Khan K. M., Collier A. D., Echevarria D. J. (2015). Modeling PTSD in the zebrafish: are we there yet? Behav. Brain Res. 276, 151–160. 10.1016/j.bbr.2014.05.005 – DOI – PubMed

Leave a Reply